Skip to content

Drug interactions

Dabigatran etexilate + Tucatinib

Severity: Moderate

Dabigatran etexilate and Tucatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tucatinib inhibits P-glycoprotein and may raise dabigatran concentrations, increasing bleeding risk.

What this interaction means in plain words

Dabigatran etexilate and Tucatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Dabigatran etexilate belongs to Cardiovascular; Tucatinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Tucatinib inhibits intestinal P-glycoprotein efflux of dabigatran etexilate, increasing exposure.

What to do

Monitor for bleeding and renal function, and consider reducing the dabigatran dose; avoid in significant renal impairment.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dabigatran etexilate and Tucatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Dabigatran etexilate with Tucatinib?

MediHelp rates the interaction as moderate. Dabigatran etexilate and Tucatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Tucatinib inhibits P-glycoprotein and may raise dabigatran concentrations, increasing bleeding risk.

How serious is the interaction between Dabigatran etexilate and Tucatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for bleeding and renal function, and consider reducing the dabigatran dose; avoid in significant renal impairment.

What other medicines interact with Dabigatran etexilate?

MediHelp also lists interactions of Dabigatran etexilate with, for example, Defibrotide, Ketorolac, Mifepristone. The full list is on the Dabigatran etexilate page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in